drugs

Health economist Susan Ettner, physician-scientist Donald Kohn and cancer researcher Dennis Slamon are among the 100 new members of the academy’s class of 2026.

Substance-using adolescents were more likely to report psychological distress and think about or attempt suicide.

A UCLA-led team has developed a tougher, higher-sensitivity wearable platform for continuous monitoring of important molecules.

Neurologist S. Thomas Carmichael, lung specialist Paul W. Noble and public health pioneer Ninez A. Ponce are UCLA's newest members.

The findings are the culmination of many years of investigation into ibudilast, a drug approved in Japan.

For World Parkinson’s Day, UCLA neurologist and Parkinson’s expert Dr. Jeff Bronstein answered questions about the causes, symptoms and treatment of PD.

UCLA Health psychiatrist says medication could remove barriers to treatment for service members who experienced trauma.

Using small 3D models that mimic a patient’s tumor, UCLA researchers can quickly test hundreds of potential drugs.

Faculty projects range from protecting incarcerated people to advocacy on behalf of renters and support for people with substance use issues.

A UCLA Dentistry–led team has received a $5 million federal grant to develop an effective, non-addictive synthetic cannabinoid.

UCLA chemists have developed a method for producing a form of the substance that acts more predictably and consistently.

The two-year grants are meant to further scientific understanding of cannabis and inform efforts to shape public policy.

The findings suggest a need for better public health policies aimed at mental health and substance use disorders.

In producing lissodendoric acid A, the team used a method they say may help accelerate the process of drug discovery.

Can drugs like psilocybin and ecstasy effectively treat depression, addiction and other conditions? UCLA researchers are working to find out.

The increase is attributable to drugs becoming more dangerous, rather than to drug use becoming more common, according to a UCLA study.

OD mortality rates increased during the first year of the COVID-19 crisis for all groups studied and were highest among Native Americans.

Research brief: Additional services to monitor the drug’s potential side effects account for nearly 20% of its total costs, a UCLA-led study shows.

A UCLA study shows that in the 2000s, physicians prescribed opioids more frequently to whites suffering from back pain than to patients of color.

A UCLA clinical trial provides evidence that the prescription drug varenicline can aid those who want to quit smoking and reduce their drinking.

Despite a government initiative to improve access to end-of-life painkillers, dispensing levels in the wealthiest areas still far outpace the rest of the country.

Research brief: Even successfully treated HIV-infected adults are at increased of many diseases more commonly associated with aging.

The team will investigate the mechanisms of treatment resistance, laying the groundwork for new and improved combination therapies.

The immunotherapy drug combination is currently being reviewed for approval under a new FDA pilot program.

Panelists at a Zócalo/UCLA Downtown event, which included two UCLA faculty, discussed the factors that contribute to the state’s messy cannabis regulation system.